Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Affiliations

• ¹ The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
• ² Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
• ³ Public Health England, Salisbury, UK.
• ⁴ The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Daniel.Jenkin@ndm.ox.ac.uk.
• ⁵ Nuffield Department of Medicine, University of Oxford, Oxford, UK.
• ⁶ Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
• ⁷ Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.Pollard@paediatrics.ox.ac.uk.